MMedication Read More Nasal spray sold nationwide recalled. See impacted products.December 21, 2025 Something you bought was just recalled. What does that mean? What happens when something you purchase is recalled?…
MMedication Read More Aptar’s Bidose Nasal System Delivers CARDAMYSTâ„¢ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)December 19, 2025 Milestone Pharmaceuticals received U.S. Food and Drug Administration approval of CARDAMYST for the conversion of acute symptomatic episodes…
MMedication Read More FDA voucher program has led to political interference in drug reviews, staffers sayDecember 19, 2025 WASHINGTON — A new program intended to fast-track drug reviews at the Food and Drug Administration is quickly…
MMedication Read More Meta urged by state AGs to regulate weight loss drug adsDecember 18, 2025 More than three dozen state attorneys general are urging Meta to better enforce its policies to thwart a…
HHealthcare Read More Lilly to build $6 billion facility to manufacture active pharmaceutical ingredients in AlabamaDecember 13, 2025 Huntsville site will focus on domestic production of small molecule synthetic and peptide medicines, including Lilly’s oral GLP-1,…
MMedication Read More Eli Lilly’s weight loss drug retatrutide clears first late-stage studyDecember 12, 2025 The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike…
HHealth Read More Higher PFAS levels reduce blood sugar improvements after teen bariatric surgeryDecember 5, 2025 A new USC study shows teens with higher blood levels of per- and polyfluoroalkyl substances (PFAS) measured before…
HHealthcare Read More WHO backs use of GLP-1 therapies for obesity, warns access will remain limitedDecember 2, 2025 A view shows The World Health Organization (WHO) headquarters in Geneva, Switzerland, Jan. 28, 2025. Denis Balibouse |…
HHealth Read More Contributors to top psychiatry journals fail to disclose industry paymentsDecember 1, 2025 Amid ongoing concern over conflicts of interest that may affect medical practice, a new study found that 14%…
MMedication Read More Lilly cuts price for obesity drug ZepboundDecember 1, 2025 Trump announces lower prices coming for GLP-1 drugs Zepbound, Wegovy President Donald Trump announces discounted pricing for Zepbound…
MMedication Read More Ozempic pill fails to slow Alzheimer’s diseaseNovember 28, 2025 Ozempic warning: Experts warn of side effects from weight loss drug Experts are warning of the possible side…
HHealthcare Read More Health Care Roundup: Market TalkNovember 25, 2025 The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET,…